Cardiovascular Diseases Clinical Trial
Official title:
Fast Track Program to Create a Web-Based Cardiovascular Intervention for the Workplace
Heart disease is the leading cause of death in the United States, accounting for approximately 700,000 deaths a year. Heart disease can take many forms, including heart attacks, coronary artery disease, aneurysms, high blood pressure, and strokes. However, people can change things in their life to reduce the risk of getting heart disease. This study will first create an Internet-based program to help teach people about reducing heart disease risk and will then test the program in a workplace setting.
Heart disease, or cardiovascular disease, refers to a range of diseases including coronary
artery disease, heart attack, heart failure, high blood pressure, and stroke. These diseases
are all related to problems with the heart and blood vessels, and collectively are the
leading cause of death in the United States. Heart attacks or coronary artery disease
sometimes have warning signs, but both can occur without warning. Approximately half of all
heart attacks are fatal. Forty percent of all deaths in the United States are the result of
heart disease.
Certain factors can predict whether people get heart disease. Some of these factors, like
biological sex or genes inherited from a person's family, cannot be changed, but many others
can. Not smoking, eating well, exercising regularly, and maintaining a healthy weight are
some of the things people can do to lower their risk of heart disease. This study will
develop and then test an Internet-based program that teaches people about heart health and
supports them in changing behaviors that put them at risk for heart disease.
This study will be divided into two phases. In the first phase, researchers will create the
Heart Healthy program, show it to focus groups, and try to improve it based on their
comments. The goals of the program are to educate users in the fundamentals of heart health
and risk factors for heart disease and to provide a system for starting and sustaining
lifestyle changes that reduce risk of heart disease. The program will be designed for
employee use in a workplace, and a tool kit will be developed for managers to supplement the
employee program. The prototype will include modified segments from existing Web-based
programs created by a non-profit organization, the ISA Group. The design of the program will
be guided by feedback from employees and managers who use it and from experts in cardiology
and epidemiology.
In the second phase, the program will be tested in a work site. Employees at risk for heart
disease will be recruited and randomly assigned to receive either the Healthy Heart program
or treatment as usual. Before and after the intervention, participants will be assessed on
knowledge gained, attitudes changed, alterations in health behavior, and reductions in
cardiovascular risk. Managers who receive the supplementary program will be tested in
knowledge gained and plans for policy or procedural changes. The ultimate goal of this phase
is to fully develop the Healthy Heart program for use in industry and health care settings.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|